SS Innovations International (SSII) Capital Expenditures Growth (3y) (2020 - 2026)

SS Innovations International (SSII) Capital Expenditures Growth (3y) (2020 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capex Growth (3y) (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn	-0.66%
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn	9.94%
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn	8.89%
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn	10.89%
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn	11.78%
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn	12.81%
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn	12.62%
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn	19.51%
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn	9.52%
10	SS Innovations International	714.49 Mn	692.19 Mn	7.10 Mn	68.45%

Download Data